Michael Morreale

Michael Morreale

Auto-generated profile, based on publicly available information

Michael Morreale

Department of Psychological & Brain Sciences, University of Delaware

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in The Journal of ECT
Verified
Journal Article
Open access
PZPeter P. Zandi
Peter P. Zandi
MMMichael Morreale
Michael Morreale
IRIrving M. Reti
Irving M. Reti
DMDaniel F. Maixner
Daniel F. Maixner
WMWilliam M. McDonald
William M. McDonald
RWRichard D. Weiner
Richard D. Weiner
Electroconvulsive therapy (ECT) is a highly therapeutic and cost-effective treatment for severe and/or treatment-resistant major depression. However, because of the varied clinical practices, there is a great deal of heterogeneity in how ECT is delivered and documented. This represents both an opportunity to study how differences in implementation influence clinical outcomes and a challenge for carrying out coordinated quality improvement and research efforts across multiple ECT centers. The National Network of Depression Centers, a consortium of 26+ US academic medical centers of excellence providing care for patients with mood disorders, formed a task group with the goals of promoting best clinical practices for the delivery of ECT and to facilitate large-scale, multisite quality improvement and research to advance more effective and safe use of this treatment modality. The National Network of Depression Centers Task Group on ECT set out to define best practices for harmonizing the clinical documentation of ECT across treatment centers to promote clinical interoperability and facilitate a nationwide collaboration that would enable multisite quality improvement and longitudinal research in real-world settings. This article reports on the work of this effort. It focuses on the use of ECT for major depressive disorder, which accounts for the majority of ECT referrals in most countries. However, most of the recommendations on clinical documentation proposed herein will be applicable to the use of ECT for any of its indications.

21 June 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTManjusha Thakar
Manjusha Thakar
YHYue Hu
Yue Hu
MMMichael Morreale
Michael Morreale
LLLane Lerner
Lane Lerner
WLWan Ying Lin
Wan Ying Lin
Nita AhujaNita Ahuja
Nita Ahuja
Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second leading cause of cancer mortality by 2030. PDAC remains resistant to the majority of systemic chemotherapies. In this paper, we explore if epigenetic sensitization can improve chemotherapy response in PDAC. Multiple PDAC cell lines were tested with serial concentrations of the epigenetic modulators 5-azacitidine (Aza) and guadecitabine (SGI-110). Guadecitabine was effective at inhibiting the expression of DNA Methyltransferase 1 (DNMT1) and in decreasing cell viability at nanomolar concentrations. We also report that guadecitabine has increased efficacy following a delay period or as we reference, a ‘rest period’. Sensitization with guadecitabine improved response to the chemotherapeutic agent–Irinotecan- as measured by decreased cell viability and accompanied by an increase in caspase activity. Additional studies are needed to understand the mechanism of action.

1 October 2024 in Health Psychology
Verified
Journal Article
Closed access
HBHannah A. Brownlee
Hannah A. Brownlee
ESEmily C. Soriano
Emily C. Soriano
MLM. James Lenhard
M. James Lenhard
AFAlyssa L. Fenech
Alyssa L. Fenech
MMMichael Morreale
Michael Morreale
JLJean-Philippe Laurenceau
Jean-Philippe Laurenceau
This study aimed to determine whether invisible social control provided by a romantic partner is associated with improved objective glucose outcomes for patients with Type 2 diabetes. Social control reflects a partner's attempt to modify or influence a patient's health behaviors. We hypothesized that the best outcome for all continuous glucose monitoring measures would be captured by an interaction condition reflecting invisible social control. Patients with Type 2 diabetes and their partners (N = 63 couples) completed an 8-day daily diary period between 2016 and 2017. Self-report measures of social control receipt and provision were obtained each evening from patients and partners and patients wore a continuous glucose monitor throughout the diary period. Outcomes of daily glucose mean, standard deviation, time in range, and coefficient of variation were computed and two-way interactions between social control receipt and social control provision were probed and plotted. The two-way interaction significantly predicted daily glucose mean, standard deviation, and time in range, such that when patients reported no social control receipt, but partners reported social control provision, patients showed improvements in objective glucose measures. We found no significant effect for coefficient of variation. This study was the first to use an invisible social control framework to examine the daily dyadic associations between partner social control provision, patient social control receipt, and four objectively measured continuous glucose monitoring outcomes. Findings suggest that the visibility of social control provided by a romantic partner may be predictive of glycemic control in patients with Type 2 diabetes. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

24 March 2025 in Psycho-Oncology
Verified
Journal Article
Closed access
MMMichael Morreale
Michael Morreale
AFAlyssa L. Fenech
Alyssa L. Fenech
HBHannah A. Brownlee
Hannah A. Brownlee
SSScott Siegel
Scott Siegel
JLJean‐Philippe Laurenceau
Jean‐Philippe Laurenceau

5 July 2021 in Journal of Clinical Psychology
Verified
Journal Article
Open access
PDF file
MMMichael Morreale
Michael Morreale
CHCalliope Holingue
Calliope Holingue
JSJack Samuels
Jack Samuels
GNGerald Nestadt
Gerald Nestadt
Background: Obsessive‐compulsive personality disorder (OCPD) is characterized by pervasive and persistent traits including preoccupation with orderliness, perfectionism, and control. Relatively little is known about the potential relationship between OCPD traits and physical health.Methods: We investigated the association between OCPD traits and several self‐reported medical conditions in 249 individuals followed prospectively from 1981 until 2004/2005 as part of the Epidemiological Catchment Area.Results: The OCPD trait score was inversely related to hypertension in males, in models unadjusted (OR = 0.66; 95% CI, 0.45–0.90) and adjusted (OR = 0.70; 95% CI, 0.47–0.95) for sociodemographic variables. Perfectionism was inversely related to hypertension in the unadjusted models for men (OR = 0.34; 95% CI, 0.12–0.89). Indecisiveness was positively associated with heart conditions in adjusted models for women (OR = 3.46; 95% CI, 1.11–10.52).Conclusion: OCPD traits are associated with cardiovascular health in both sexes. Further studies are needed to understand the specificity of these relationships, as well as to determine the underlying mechanism.

1 April 2026 in Health Psychology
Verified
Journal Article
Closed access
MMMichael Morreale
Michael Morreale
ESEmily C. Soriano
Emily C. Soriano
AFAlyssa L. Fenech
Alyssa L. Fenech
HBHannah A. Brownlee
Hannah A. Brownlee
SSScott D. Siegel
Scott D. Siegel
JLJean-Philippe Laurenceau
Jean-Philippe Laurenceau
The objective of this study was to examine how diabetes-related emotional distress and depressive symptoms are uniquely related to objective measures of glycemic outcomes in people with Type 2 diabetes mellitus (T2DM). Existing research demonstrates that diabetes distress is better able to account for glycemic outcomes when compared to depressive symptoms. However, few studies have focused on this comparison when assessing glycemic outcomes using continuous glucose monitoring (CGM) indices specifically in T2DM populations. Sixty-three adults diagnosed with T2DM were recruited from an outpatient endocrinology clinic. Diabetes-related emotional distress and depressive symptoms were assessed via self-report measures. Glycemic outcomes were measured using the gold standard hemoglobin A1c and 7 days of CGM data (measuring both glucose concentration levels and variation). The relationship between diabetes-related emotional distress (operationalized as a latent factor), depressive symptomatology, and glycemic outcome metrics (i.e., hemoglobin A1c and CGM-based) was evaluated using structural equation modeling. Moderate-sized associations were observed between diabetes-related emotional distress and a majority of the glycemic outcome metrics when controlling for depressive symptoms. No associations were observed between depressive symptoms and glycemic outcome metrics when controlling for diabetes-related emotional distress. The findings suggest that following a T2DM diagnosis, diabetes-related emotional distress is better able to account for variance in glycemic outcomes when compared to depressive symptoms. (PsycInfo Database Record (c) 2026 APA, all rights reserved).